GAA (Lysosomal acid alpha-glucosidase / acid maltase) — review notes

UniProtKB:P10253 (LYAG_HUMAN), gene GAA, HGNC:4065, human (NCBITaxon:9606). 952 aa precursor.

Core biology (from UniProt P10253 + literature)

• Enzyme: Lysosomal alpha-glucosidase, EC 3.2.1.20 ("acid maltase"). Glycoside hydrolase family 31 (GH31; CAZy GH31). Same family as intestinal maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI).
• Function (UniProt CC): "Essential for the degradation of glycogen in lysosomes ... Has highest activity on alpha-1,4-linked glycosidic linkages, but can also hydrolyze alpha-1,6-linked glucans." [file:human/GAA/GAA-uniprot.txt]
• Catalytic activity (UniProt CC): "Hydrolysis of terminal, non-reducing (1->4)-linked alpha-D-glucose residues with release of alpha-D-glucose.; EC=3.2.1.20" [file:human/GAA/GAA-uniprot.txt]
• Mechanism (PMID:29061980, full text): GH31 Koshland double displacement, retaining. Catalytic nucleophile D518, acid/base D616. Within the lysosome no debranching enzyme is present, so GAA must hydrolyze both alpha-1,4 and alpha-1,6 linkages; clear preference for alpha-1,4 (32-fold higher specificity constant on maltose vs isomaltose). This is DISTINCT from cytosolic glycogenolysis (phosphorylase + debranching enzyme). PMID:29061980
• Catalytic site (PMID:1856189, abstract): Asp-518 predicted essential carboxylate; Trp-516 and Asp-518 critical for catalytic function; competitive inhibition with glycogen as natural substrate and 4-MU-alpha-D-glucopyranoside as artificial substrate. PMID:1856189
• Biogenesis / targeting (PMID:29061980 full text): "GAA is synthesized as a 110 kDa glycoprotein, which is targeted to the lysosome via the mannose-6-phosphate receptor and undergoes in the late endosomal/lysosomal compartment a series of proteolytic and N-glycan processing events to yield a mature active form composed of four tightly associated peptides." UniProt PTM: phosphorylation of mannose residues ensures transport via M6P receptor; proteolytic processing yields 76 kDa/70 kDa forms.
• Localization: Lysosome / lysosome lumen (UniProt SUBCELLULAR LOCATION: Lysosome, Lysosome membrane, ECO PubMed:17897319). Structure (PMID:29061980) is the mature lumenal enzyme.

Disease

• Pompe disease (GSD II, acid maltase deficiency): autosomal recessive lysosomal storage disease from GAA deficiency; lysosomal glycogen accumulation, cardiac + skeletal muscle damage. IOPD (infantile, MIM:232300): cardiomyopathy + muscular hypotonia. LOPD (late-onset, MIM:621314): limb-girdle myopathy, respiratory muscle failure. Hundreds of GAA mutations. [PMID:29061980; UniProt DISEASE]
• Therapy: rhGAA (alglucosidase alfa / Myozyme) approved 2006 for ERT; M6P-receptor-mediated uptake into muscle. Pharmacological chaperones (DNJ, NAC) also studied. [PMID:29061980; PMID:9505277]
• ERT uptake (PMID:9505277, abstract): recombinant hGAA (110 kD precursor -> 76 kD mature within 24 h) corrects intracellular GAA + glycogen in deficient fibroblasts/myoblasts; endocytosed enzyme localizes to lysosomes; endocytosis inhibited by M6P; M6P-receptor-mediated. PMID:9505277

Annotation review reasoning

MF (all converge on the same catalytic activity)

• GO:0004558 alpha-1,4-glucosidase activity — CORE. Supported by EXP/IDA (PMID:18429042, 1856189, 7717400, 29061980, 9505277, 24417) + IBA + IEA(EC 3.2.1.20). ACCEPT the experimental ones; IBA ACCEPT; IEA (EC/InterPro) ACCEPT.
• GO:0090599 alpha-glucosidase activity — parent of 0004558. EXP(PMID:5264799 abstract=title only re alpha-1,4 & alpha-1,6 glucosidase absence in GSD II) + TAS(Reactome). Less specific than 0004558; KEEP_AS_NON_CORE (redundant broader parent). Not wrong.
• GO:0043896 glucan 1,6-alpha-glucosidase activity — IDA (PMID:24417). GAA does hydrolyze alpha-1,6 branches (secondary activity; PMID:29061980 confirms, 32x lower). Real but minor/secondary activity. ACCEPT as a genuine secondary activity (KEEP_AS_NON_CORE — not the core alpha-1,4 activity).
• GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds — IEA InterPro. Correct but broad parent. KEEP_AS_NON_CORE.
• GO:0030246 carbohydrate binding — IEA InterPro (IPR011013 = Galactose mutarotase-like / Gal_mutarotase_sf_dom). GAA does bind its carbohydrate substrate; there's a documented secondary carbohydrate-binding site (trefoil domain) in PMID:29061980. However this is a generic domain-based mapping; substrate binding is subsumed under the hydrolase MF. MARK_AS_OVER_ANNOTATED (uninformative; the meaningful MF is the glucosidase activity).

BP

• GO:0005980 glycogen catabolic process — CORE. IBA + IEA(ARBA) + TAS(Reactome R-HSA-70221) + IDA(PMID:29061980, 9505277). ACCEPT experimental/IBA; the lysosomal glycogen degradation IS the core BP.
• GO:0061723 glycophagy — autophagy-mediated delivery + lysosomal degradation of glycogen; this is precisely the pathway GAA acts in. IEA(Ensembl, from mouse P70699) + IMP(PMID:5264799). The IMP via GAA-deficiency phenotype (absence of activity in GSD II) supports involvement. ACCEPT / KEEP_AS_NON_CORE (glycophagy is the physiological process; glycogen catabolic process is the direct MF-linked BP).
• GO:0007040 lysosome organization — IBA + IMP(PMID:7717400). GAA deficiency causes lysosomal glycogen storage -> enlarged/disrupted lysosomes; the IMP is inferred from a leaky-splicing patient phenotype paper (delayed-onset GSD II). This is a secondary/downstream consequence, not GAA's molecular role. Reactome/IBA also carry it. KEEP_AS_NON_CORE (downstream/consequence of loss, not a direct organizing function).
• GO:0005975 carbohydrate metabolic process — IEA InterPro. Broad parent of glycogen catabolism. KEEP_AS_NON_CORE.
• GO:0005984 disaccharide metabolic process — IEA ARBA. GAA hydrolyzes maltose (a disaccharide) in vitro (acid maltase). Plausible but reflects in-vitro substrate scope, not physiological role. MARK_AS_OVER_ANNOTATED.
• GO:0000023 maltose metabolic process — IC (from GO:0004558), PMID:9505277. Maltose is an in-vitro substrate (4-MU-glucoside / maltose assays); no evidence GAA physiologically metabolizes dietary maltose (that's intestinal MGAM/SI). IC-inferred from the MF. MARK_AS_OVER_ANNOTATED.
• GO:0005985 sucrose metabolic process — IC (from GO:0004558), PMID:9505277. GAA is not a sucrase; sucrose metabolism is SI. Over-broad IC inference. MARK_AS_OVER_ANNOTATED (borderline REMOVE, but IC anchored on a real MF; not demonstrably an EC-mapping error, keep conservative).
• GO:0006006 glucose metabolic process — IC (from GO:0004558). GAA releases glucose from glycogen; broad parent. KEEP_AS_NON_CORE.
• GO:0002086 diaphragm contraction — IMP(PMID:16917947, LOPD mutation profile). This is a disease-consequence phenotype (respiratory/diaphragm failure in LOPD), not a GAA molecular role in muscle contraction. Highly indirect. MARK_AS_OVER_ANNOTATED / KEEP_AS_NON_CORE (physiological consequence of deficiency).

CC

• GO:0005764 lysosome — CORE. IEA(UniProt) + IDA(PMID:9505277). ACCEPT.
• GO:0043202 lysosomal lumen — CORE (mature soluble lumenal enzyme). TAS(Reactome x2). ACCEPT.
• GO:0005765 lysosomal membrane — IEA(SubCell) + HDA(PMID:17897319 lysosomal membrane proteome). GAA is a soluble lumenal enzyme but is membrane-associated / co-purifies with lysosomal membrane (UniProt SUBCELLULAR LOCATION lists "Lysosome membrane" ECO PubMed:17897319). KEEP_AS_NON_CORE (peripheral association; not integral membrane).
• GO:0016020 membrane — IEA(Ensembl) + HDA(PMID:19946888 NK cell membrane proteome). Generic; MARK_AS_OVER_ANNOTATED.
• GO:0005886 plasma membrane — TAS(Reactome neutrophil degranulation exocytosis, x3). GAA appears in neutrophil granule/degranulation Reactome pathways (granule membrane proteins exocytosed to PM). Reflects proteomic detection in neutrophil granules, not the primary lysosomal function. KEEP_AS_NON_CORE / MARK_AS_OVER_ANNOTATED.
• GO:0035577 azurophil granule membrane; GO:0070821 tertiary granule membrane; GO:0101003 ficolin-1-rich granule membrane — TAS(Reactome neutrophil degranulation). Neutrophil granules are lysosome-related organelles; GAA detected there by proteomics. KEEP_AS_NON_CORE (secretory-lysosome/granule localization, not core).
• GO:0120282 autolysosome lumen — IEA(Ensembl, from mouse). Autolysosome = fusion of autophagosome + lysosome; where autophagy-delivered glycogen is degraded. Consistent with glycophagy role. KEEP_AS_NON_CORE.
• GO:0070062 extracellular exosome — HDA(PMID:23533145 prostatic-secretion exosomes; PMID:19056867 urinary exosomes). Generic high-throughput exosome proteomics detection. MARK_AS_OVER_ANNOTATED.

Core functions summary

1. MF GO:0004558 alpha-1,4-glucosidase activity; directly involved in BP GO:0005980 glycogen catabolic process; located_in GO:0043202 lysosomal lumen (and GO:0005764 lysosome). This is the well-established core: lysosomal degradation of glycogen to glucose at acidic pH.